-
1
-
-
0034720161
-
Myelofibrosis with myeloid metaplasia
-
Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342(17):1255-1265.
-
(2000)
N Engl J Med.
, vol.342
, Issue.17
, pp. 1255-1265
-
-
Tefferi, A.1
-
2
-
-
30344484239
-
The v617f jak2 mutation and the myeloproliferative disorders
-
Percy MJ, McMullin MF. The V617F JAK2 mutation and the myeloproliferative disorders. Hematol Oncol. 2005;23(3-4):91-93.
-
(2005)
Hematol Oncol
, vol.23
, Issue.3-4
, pp. 91-93
-
-
Percy, M.J.1
McMullin, M.F.2
-
3
-
-
34548240698
-
Role of jak2 in the pathogenesis and therapy of myeloproliferative disorders
-
Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007;7(9):673-683.
-
(2007)
Nat Rev Cancer
, vol.7
, Issue.9
, pp. 673-683
-
-
Levine, R.L.1
Pardanani, A.2
Tefferi, A.3
Gilliland, D.G.4
-
4
-
-
77950684805
-
Preclinical characterization of the selective Jak1/2 inhibitor incb018424: Therapeutic implications for the treatment of myeloproliferative neoplasms
-
Quintás-Cardama A, Vaddi K, Liu P, et al. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood. 2010;115(15):3109-3117.
-
(2010)
Blood
, vol.115
, Issue.15
, pp. 3109-3117
-
-
Quintás-Cardama, A.1
Vaddi, K.2
Liu, P.3
-
5
-
-
84857837774
-
Jak inhibition with ruxolitinib versus best available therapy for myelofibrosis
-
Harrison C, Kiladjian JJ, Al-Ali HK, et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med. 2012; 366(9):787-798.
-
(2012)
N Engl J Med
, vol.366
, Issue.9
, pp. 787-798
-
-
Harrison, C.1
Kiladjian, J.J.2
Al-Ali, H.K.3
-
6
-
-
84872260963
-
Jak2 inhibitors for myelofibrosis: Why are they effective in patients with and without jak2v617f mutation?
-
Santos FP, Verstovsek S. JAK2 inhibitors for myelofibrosis: why are they effective in patients with and without JAK2V617F mutation? Anticancer Agents Med Chem. 2012;12(9): 1098-1109.
-
(2012)
Anticancer Agents Med Chem
, vol.12
, Issue.9
, pp. 1098-1109
-
-
Santos, F.P.1
Verstovsek, S.2
-
9
-
-
34547108380
-
Jak-stat signaling: From interferons to cytokines
-
Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007;282(28):20059-20063.
-
(2007)
J Biol Chem.
, vol.282
, Issue.28
, pp. 20059-20063
-
-
Schindler, C.1
Levy, D.E.2
Decker, T.3
-
10
-
-
77949759544
-
Loss of jak2 selectively suppresses dc-mediated innate immune response and protects mice from lethal dose of lps-induced septic shock
-
Zhong J, Yang P, Muta K, et al. Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS ONE. 2010;5(3):e9593.
-
(2010)
Plos ONE
, vol.5
, Issue.3
-
-
Zhong, J.1
Yang, P.2
Muta, K.3
-
11
-
-
78049422716
-
Ifn-g activated jak1 shifts cd40-induced cytokine profiles in human antigen-presenting cells toward high il-12p70 and low il-10 production
-
Conzelmann M, Wagner AH, Hildebrandt A, et al. IFN-g activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production. Biochem Pharmacol. 2010;80(12): 2074-2086.
-
(2010)
Biochem Pharmacol
, vol.80
, Issue.12
, pp. 2074-2086
-
-
Conzelmann, M.1
Wagner, A.H.2
Hildebrandt, A.3
-
12
-
-
48149088642
-
Generation of antigen-specific ctl responses using rgs1 mrna transfected dendritic cells
-
Grünebach F, Erndt S, Häntschel M, Heine A, Brossart P. Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells. Cancer Immunol Immunother. 2008;57(10):1483-1491.
-
(2008)
Cancer Immunol Immunother
, vol.57
, Issue.10
, pp. 1483-1491
-
-
Grünebach, F.1
Erndt, S.2
Häntschel, M.3
Heine, A.4
Brossart, P.5
-
13
-
-
79953677184
-
Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone
-
Kock G, Bringmann A, Held SA, Daecke S, Heine A, Brossart P. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone. Blood. 2011;117(13):3569-3574.
-
(2011)
Blood
, vol.117
, Issue.13
, pp. 3569-3574
-
-
Kock, G.1
Bringmann, A.2
Held, S.A.3
Daecke, S.4
Heine, A.5
Brossart, P.6
-
14
-
-
0026481133
-
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor
-
Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J Exp Med. 1992;176(6):1693-1702.
-
(1992)
J Exp Med.
, vol.176
, Issue.6
, pp. 1693-1702
-
-
Inaba, K.1
Inaba, M.2
Romani, N.3
-
15
-
-
0033012030
-
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
-
Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223(1):77-92.
-
(1999)
J Immunol Methods
, vol.223
, Issue.1
, pp. 77-92
-
-
Lutz, M.B.1
Kukutsch, N.2
Ogilvie, A.L.3
-
16
-
-
77949830320
-
Alternative cross-priming through ccl17-ccr4-mediated attraction of ctls toward nkt cell-licensed dcs
-
Semmling V, Lukacs-Kornek V, Thaiss CA, et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol. 2010;11(4):313-320.
-
(2010)
Nat Immunol
, vol.11
, Issue.4
, pp. 313-320
-
-
Semmling, V.1
Lukacs-Kornek, V.2
Thaiss, C.A.3
-
17
-
-
28444455582
-
Ppar-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the map kinase and nf-kappab pathways
-
Appel S, Mirakaj V, Bringmann A, Weck MM, Grünebach F, Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood. 2005;106(12):3888-3894.
-
(2005)
Blood
, vol.106
, Issue.12
, pp. 3888-3894
-
-
Appel, S.1
Mirakaj, V.2
Bringmann, A.3
Weck, M.M.4
Grünebach, F.5
Brossart, P.6
-
18
-
-
33947383077
-
Zoledronic acid inhibits the function of toll-like receptor 4 ligand activated monocyte-derived dendritic cells
-
Bringmann A, Schmidt SM, Weck MM, et al. Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia. 2007;21(4):732-738.
-
(2007)
Leukemia
, vol.21
, Issue.4
, pp. 732-738
-
-
Bringmann, A.1
Schmidt, S.M.2
Weck, M.M.3
-
19
-
-
63449141174
-
Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the ppargamma ligand troglitazone
-
von Schwarzenberg K, Held SA, Schaub A, Brauer KM, Bringmann A, Brossart P. Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazone. Cell Mol Life Sci. 2009;66(7):1295-1308.
-
(2009)
Cell Mol Life Sci
, vol.66
, Issue.7
, pp. 1295-1308
-
-
Von Schwarzenberg, K.1
Held, S.A.2
Schaub, A.3
Brauer, K.M.4
Bringmann, A.5
Brossart, P.6
-
20
-
-
84877820487
-
Imatinib mesylate and nilotinib affect mhc-class i presentation by modulating the proteasomal processing of antigenic peptides
-
Held SA, Duchardt KM, Tenzer S, et al. Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides. Cancer Immunol Immunother. 2013;62(4):715-726.
-
(2013)
Cancer Immunol Immunother
, vol.62
, Issue.4
, pp. 715-726
-
-
Held, S.A.1
Duchardt, K.M.2
Tenzer, S.3
-
21
-
-
0031055468
-
Construction of adenovirus vectors through cre-lox recombination
-
Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 1997; 71(3):1842-1849.
-
(1997)
J Virol
, vol.71
, Issue.3
, pp. 1842-1849
-
-
Hardy, S.1
Kitamura, M.2
Harris-Stansil, T.3
Dai, Y.4
Phipps, M.L.5
-
22
-
-
0035033218
-
Transfer of hepatitis b virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier
-
Sprinzl MF, Oberwinkler H, Schaller H, Protzer U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol. 2001;75(11): 5108-5118.
-
(2001)
J Virol
, vol.75
, Issue.11
, pp. 5108-5118
-
-
Sprinzl, M.F.1
Oberwinkler, H.2
Schaller, H.3
Protzer, U.4
-
23
-
-
77950606986
-
Bioluminescence imaging allows measuring cd8 t cell function in the liver
-
Stabenow D, Frings M, Trück C, et al. Bioluminescence imaging allows measuring CD8 T cell function in the liver. Hepatology. 2010; 51(4):1430-1437.
-
(2010)
Hepatology
, vol.51
, Issue.4
, pp. 1430-1437
-
-
Stabenow, D.1
Frings, M.2
Trück, C.3
-
24
-
-
0033151538
-
Secondary lymphoid-tissue chemokine (slc) is chemotactic for mature dendritic cells
-
Chan VW, Kothakota S, Rohan MC, et al. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood. 1999;93(11):3610-3616.
-
(1999)
Blood
, vol.93
, Issue.11
, pp. 3610-3616
-
-
Chan, V.W.1
Kothakota, S.2
Rohan, M.C.3
-
25
-
-
84864716411
-
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis
-
Fleischmann R, Kremer J, Cush J, et al; ORAL Solo Investigators. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N Engl J Med. 2012;367(6):495-507.
-
(2012)
N Engl J Med.
, vol.367
, Issue.6
, pp. 495-507
-
-
Fleischmann, R.1
Kremer, J.2
Cush, J.3
-
26
-
-
0028289244
-
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
-
Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-1118.
-
(1994)
J Exp Med.
, vol.179
, Issue.4
, pp. 1109-1118
-
-
Sallusto, F.1
Lanzavecchia, A.2
-
28
-
-
77949529017
-
Granzyme b produced by human plasmacytoid dendritic cells suppresses t-cell expansion
-
Jahrsdörfer B, Vollmer A, Blackwell SE, et al. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood. 2010;115(6):1156-1165.
-
(2010)
Blood
, vol.115
, Issue.6
, pp. 1156-1165
-
-
Jahrsdörfer, B.1
Vollmer, A.2
Blackwell, S.E.3
-
29
-
-
70349397244
-
Jak3 is involved in dendritic cell maturation and ccr7-dependent migration
-
Rivas-Caicedo A, Soldevila G, Fortoul TI, Castell-Rodríguez A, Flores-Romo L, García-Zepeda EA. Jak3 is involved in dendritic cell maturation and CCR7-dependent migration. PLoS ONE. 2009; 4(9):e7066.
-
(2009)
Plos ONE
, vol.4
, Issue.9
-
-
Rivas-Caicedo, A.1
Soldevila, G.2
Fortoul, T.I.3
Castell-Rodríguez, A.4
Flores-Romo, L.5
García-Zepeda, E.A.6
-
30
-
-
84870325487
-
Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by jak inhibitors
-
Yarilina A, Xu K, Chan C, Ivashkiv LB. Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 2012;64(12):3856-3866.
-
(2012)
Arthritis Rheum
, vol.64
, Issue.12
, pp. 3856-3866
-
-
Yarilina, A.1
Xu, K.2
Chan, C.3
Ivashkiv, L.B.4
-
31
-
-
84857239335
-
The jak inhibitor cp-690,550 (tofacitinib) inhibits tnf-induced chemokine expression in fibroblast-like synoviocytes: Autocrine role of type i interferon
-
Rosengren S, Corr M, Firestein GS, Boyle DL. The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. Ann Rheum Dis. 2012;71(3): 440-447.
-
(2012)
Ann Rheum Dis
, vol.71
, Issue.3
, pp. 440-447
-
-
Rosengren, S.1
Corr, M.2
Firestein, G.S.3
Boyle, D.L.4
-
32
-
-
80053437858
-
Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus
-
Tsai YT, Chen YH, Chang DM, Chen PC, Lai JH. Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus. Exp Biol Med (Maywood). 2011; 236(10):1156-1165.
-
(2011)
Exp Biol Med (maywood)
, vol.236
, Issue.10
, pp. 1156-1165
-
-
Tsai, Y.T.1
Chen, Y.H.2
Chang, D.M.3
Chen, P.C.4
Lai, J.H.5
-
33
-
-
84877618100
-
An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor
-
Wysham NG, Sullivan DR, Allada G. An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor. Chest. 2013; 143(5):1478-1479.
-
(2013)
Chest
, vol.143
, Issue.5
, pp. 1478-1479
-
-
Wysham, N.G.1
Sullivan, D.R.2
Allada, G.3
-
34
-
-
84866158913
-
Jak inhibitors in psoriasis: A promising new treatment modality
-
Kwatra SG, Dabade TS, Gustafson CJ, Feldman SR. JAK inhibitors in psoriasis: a promising new treatment modality. J Drugs Dermatol. 2012; 11(8):913-918.
-
(2012)
J Drugs Dermatol
, vol.11
, Issue.8
, pp. 913-918
-
-
Kwatra, S.G.1
Dabade, T.S.2
Gustafson, C.J.3
Feldman, S.R.4
-
35
-
-
84864066214
-
Preliminary clinical activity of a topical Jak1/2 inhibitor in the treatment of psoriasis
-
Punwani N, Scherle P, Flores R, et al. Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis. J Am Acad Dermatol. 2012;67(4):658-664.
-
(2012)
J Am Acad Dermatol
, vol.67
, Issue.4
, pp. 658-664
-
-
Punwani, N.1
Scherle, P.2
Flores, R.3
-
36
-
-
80051788025
-
Preclinical evaluation of local jak1 and jak2 inhibition in cutaneous inflammation
-
Fridman JS, Scherle PA, Collins R, et al. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. J Invest Dermatol. 2011;131(9):1838-1844.
-
(2011)
J Invest Dermatol.
, vol.131
, Issue.9
, pp. 1838-1844
-
-
Fridman, J.S.1
Scherle, P.A.2
Collins, R.3
|